High materiality9/10
Sutro Biopharma assumed with a Buy at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist Financial initiates Sutro Biopharma (STRO) with a Buy; target $50.
- STRO target raised to $50 at Truist.
Key facts
- 01
Target: $50
- 02
Posted price: $26.09
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.